TRUSTEES OF DARTMOUTH COLLEGE;REATA PHARMACEUTICALS, INC.
发明人:
Michael B. SPORN,Karen T. LIBY,Gordon W. GRIBBLE,Tadashi HONDA,Robert M. Kral,Colin J. MEYER
申请号：
US15675862
公开号：
US20180161311A1
申请日:
2017.08.14
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention concerns methods for treating and preventing renal/kidney disease, insulin resistance/diabetes, fatty liver disease, and/or endothelial dysfunction/cardiovascular disease using synthetic triterpenoids, optionally in combination with a second treatment or prophylaxis.
